Key facts
- CVS Health reported strong second-quarter results.
- The company raised its 2026 profit forecast.
- CVS Health provided a tepid profit outlook for 2027.
- CVS Health shares declined following the earnings report and guidance.
CVS Health reported strong second-quarter results, boosted by a more profitable drug mix and bonus payments for its government health plans. This performance led the company to raise its 2026 profit forecast. However, the company's outlook for 2027 was described as tepid, which overshadowed the positive quarterly results and caused its shares to fall. The stock initially jumped on the earnings beat but reversed sharply lower, with management's 2027 outlook cited as a potential trigger for the decline. The company also announced $29 appointments for weight-loss drug prescriptions at its MinuteClinic.